From owner-recombination@net.bio.net Sat Oct 14 23:00:00 1995
Path: biosci!biosci!not-for-mail
From: biohelp@net.bio.net (BIOSCI Administrator)
Newsgroups: bionet.molbio.recombination
Subject: test of bionet.molbio.recombination
Date: 14 Oct 1995 18:33:54 -0700
Organization: BIOSCI International Newsgroups for Biology
Lines: 148
Distribution: world
Message-ID: <45poe2$36@net.bio.net>
NNTP-Posting-Host: net.bio.net

Test of bionet.molbio.recombination; this group is not yet ready for
operation.  Please do not post until you see an official opening
announcement herein.

				Sincerely,

				Dave Kristofferson
				BIOSCI/bionet Manager

				biosci-help@net.bio.net

----------------------------------------------------------------------

Information for RECOMBINATION/bionet.molbio.recombination

USENET newsgroup name:          bionet.molbio.recombination

Status: 			Unmoderated

One line description: 		Research on the recombination of DNA or RNA.

Mailing list name:     		RECOMBINATION

E-mail posting addresses:	recom@net.bio.net
                                recom@daresbury.ac.uk

Discussion leaders:

*Note: Area of expertise is written in brackets

Graham Dellaire,  e-mail: popa0206@po-box.mcgill.ca (b2xe@musicb.mcgill.ca)
Department of Medicine (Div. of Exp. Medicine)
McGill Univeristy,
Montreal, Quebec, Canada 
*(Genome Accessibility, Line-1 sequences, Gene Conversion and Ectopic Int.)


George Szatmari,  e-mail: szat@ere.umontreal.ca
Assistant Professor
Departement de Microbiologie et Immunologie
Universite de Montreal
CP 6128 Succursale Centre-Ville
Montreal, Quebec H3C 3J7
phone (514)343 5767  fax (514)343 5701
*(Site Specific Recombination Sytems)


Terry Chow e-mail: MDTY@musica.mcgill.ca
Associate Professor
Department of Oncology
Division of Radiation-Oncology
McGill University
Montreal General Hospital
1650 Ave. Cedar
Montreal, Quebec H3G 1A4
phone (514)934 8040 ext. 4179
fax (514)934 8220
*(Mammalian Genetics/gene therapy)


Dana Lasko e-mail: CZDL@musica.mcgill.ca
Assistant Professor of Medicine and Human Genetics
Project Director
Terry Fox Molecular Oncology Group
Lady Davis Institute for Medical Research
3755 Cote-Ste-Catherine Rd.
Montreal, PQ
Phone 340-8260 ext. 3454 (office and machine) or  ext. 5251 (lab)
Fax 340-7502
*(Replication and Recombination)



Charter:

The purpose of the RECOMBINATION newsgroup is to provide a proper
forum for the discussion of issues pertaining and involving recombination 
of DNA or RNA, in its many forms (see _Topics of Discussion_).  Primarily 
it should enable those researchers who work in recombination or aligned 
fields to communicate ideas and information, as well as, provide a chance 
for
collaboration among national and international research groups.


Topics of Discussion include:
1. Gene conversion and ectopic integration 
2. Genome accessibility and nuclear/chromosome structure and recombination
                    -Matrix attachment sites (MARS)
                    -nucleosomes, histone 1 
                    -recombination hotspots
                    -fragile sites 
                    -origins of replication
3. Effect of DNA topology on recombination (Triple strand, Z-DNA, cruciform, 
bent etc)
4. Homologous recombination vs. nonhomologous or illegitimate 
                    -comparisons between bacterial, yeast and higher 
eukaryotic recombination
                     systems (ex. fungi, mammals) 
5. Models of recombination (One-end invasion, Double strand Break Repair, 
SSA etc)
6. Site-specific recombination systems (invertase, Cre and Flp recombinase 
etc)
7. Specific recombination systems in complex organisms
                    -VDJ recombination
                    -Antigenic variation and recombination (ex. 
trypanosomes, HIV, N.gonorrhea) 
                    -Yeast mating type locus 
8. Transcription and recombination 
9. DNA replication and recombination (ex. gene amplification (DHFR etc))
10. Evolution of the Genome
                    -retroposons (Line-1, Sine's), retroviruses and 
transposons
                    -formation of gene clusters and comparative mapping
                    -recombination between other repeat elements (alpha 
satellites, telomeres)
11. DNA repair systems and recombination (DSB and mismatch repair)
                    -including DNA repair deficient diseases (ex. Xoderma 
Pigmentosum)
12. Applications of recombination
                    -Gene therapy
                    -Transgenics and gene transfer
13. Viral diversity through RNA recombination
14. Population genetics and recombination:i.e. as a source of allelic 
variation
and as a measure of genetic exchange within and between populations.

In addition this newsgroup provides:

        A forum for the exchange of information about future congresses
        and meetings in areas of molecular biology relating to recombination

        A forum for the exchange of information about textbooks, internet
        resources, visual materials, and computer programs.

        A source of quick help for last-minute troubleshooting, sources of 
materials,
        and practical advice; in areas such as
                     -Vector design for transgene experiments
                     -Gene transfer techniques
                     -Animal models and cell lines
                     -Gene therapy protocols 


Subscribers are welcome.  Contributions within the functions outlined
above are encouraged.

The newsgroup is -UNMODERATED-.


From owner-recombination@net.bio.net Sat Oct 14 23:00:00 1995
Path: biosci!NET.BIO.NET!biosci-help
From: biosci-help@NET.BIO.NET (BIOSCI Administrator)
Newsgroups: bionet.molbio.recombination
Subject: test of recom@net.bio.net
Date: 14 Oct 1995 18:35:40 -0700
Organization: BIOSCI International Newsgroups for Molecular Biology
Lines: 2
Sender: daemon@net.bio.net
Distribution: world
Message-ID: <CMM-RU.1.4.813720933.biohelp@net.bio.net>
Reply-To: biosci-help@net.bio.net
NNTP-Posting-Host: net.bio.net


test of recom@net.bio.net; please ignore.

From owner-recombination@net.bio.net Sat Oct 14 23:00:00 1995
Path: biosci!agate!howland.reston.ans.net!newsfeed.internetmci.com!news.sesqui.net!oitnews.harvard.edu!cmcl2!is2.NYU.EDU!cqw4441
From: cqw4441@is2.nyu.edu (Cheukkit  Wong)
Newsgroups: bionet.molbio.recombination
Subject: T7 RNA polymerase
Date: 15 Oct 1995 00:38:10 GMT
Organization: New York University
Lines: 2
Message-ID: <45pl5i$mh9@cmcl2.NYU.EDU>
NNTP-Posting-Host: is2.nyu.edu
X-Newsreader: TIN [version 1.2 PL2]


What is the allosteric promoter(s) with a high affinity for T4 RNA polymerase?

From owner-recombination@net.bio.net Mon Oct 16 23:00:00 1995
Path: biosci!daresbury!not-for-mail
From: BIOSCI Administrator <biosci-help@net.bio.net>
Newsgroups: bionet.molbio.recombination
Subject: test of recom@daresbury.ac.uk
Date: 17 Oct 1995 01:52:13 +0100
Lines: 1
Sender: lpddist@mserv1.dl.ac.uk
Distribution: bionet
Message-ID: <45uunt$c3g@mserv1.dl.ac.uk>
Reply-To: biosci-help@net.bio.net
Original-To: recom@dl.ac.uk

test of recom@daresbury.ac.uk, please ignore.

From owner-recombination@net.bio.net Mon Oct 16 23:00:00 1995
Path: biosci!biosci!not-for-mail
From: biohelp@net.bio.net (BIOSCI Administrator)
Newsgroups: bionet.molbio.recombination
Subject: RECOMBINATION/bionet.molbio.recombination is ready!
Date: 16 Oct 1995 19:59:13 -0700
Organization: BIOSCI International Newsgroups for Biology
Lines: 194
Distribution: world
Message-ID: <45v661$lqr@net.bio.net>
NNTP-Posting-Host: net.bio.net

The RECOMBINATION/bionet.molbio.recombination newsgroup is ready for
operation.  Please save these usage instructions for future
reference!!

PLEASE NOTE that many USENET sites do not allow automatic creation of
new USENET groups!!!  If you do not see bionet.molbio.recombination in your
newsreader within another day or two, ask your news system
administrator to act on our "newgroup" message to enable the group at
your site.  We have already done several tests and are certain that
the group is currently propagating around the network.  If he/she can
not find the newsgroup message, have them retrieve the bionet
checkgroups message from the anonymous FTP area on net.bio.net in
pub/BIOSCI/doc/bionet-checkgroups-msg.  This file contains the latest
list of bionet USENET newsgroups and can be used to update your bionet
distribution.  If the newgroup did not arrive at your site, it may
also be necessary for your news administrator to contact the upstream
computer site providing you with your newsfeed and determine if they
acted on the newgroup message.

Subscribing to this group:
--------------------------

IF YOU USE USENET NEWS: you need do nothing other than participate in
bionet.molbio.recombination when it appears in your newsreader.  Depending
upon your news software, this may entail you having to answer a prompt
indicating that you want to subscribe.  You might also try the command
"g bionet.molbio.recombination" in rn-like newsreaders.

IF YOU ARE LOCATED IN EUROPE, AFRICA, OR CENTRAL ASIA: please send the
word

help

in the body of your message to MXT@dl.ac.uk to retrieve general server
usage instructions.  To subscribe to the RECOMBINATION list, first
be sure that you are sending mail from the address at which you wish
to receive news postings, and then send
the command

SUB bionet-news.bionet.molbio.recombination

to MXT@dl.ac.uk.  This message will be automatically read by the
computer and your e-mail address will be extracted from the mail
header and added to the list.


IF YOU ARE LOCATED IN THE AMERICAS OR THE PACIFIC RIM: log in to the
computer account in which you would like to receive mail (not an
account that you use infrequently) and send a mail message to the
Internet address

biosci-server@net.bio.net

Leave the Subject: line of the message blank and enter the following
line into the body of the mail message:

subscribe recom


This message will be automatically read by our computer and your
e-mail address will be extracted from the mail header and added to the
list.


Canceling your subscription:
----------------------------

IF YOU ARE LOCATED IN EUROPE, AFRICA, OR CENTRAL ASIA: first be sure
that you are sending mail from the address at which you signed up to
receive news postings, and then send the command (in the body of your
mail message)

UNSUB bionet-news.bionet.molbio.recombination

to MXT@dl.ac.uk.  This message will be automatically read by the
computer and your e-mail address will be extracted from the mail
header and removed from the list.

IF YOU ARE LOCATED IN THE AMERICAS OR THE PACIFIC RIM: send a message
to biosci-server@net.bio.net exactly as described above for
subscribing except include the text

unsubscribe recom

in the body of the message.  Please be sure to send the message from
the account whose address matches the one on the list.  If your
address differs, we will be notified automatically and will remove you
manually from the list if we can determine what was your old address.
Please contact biosci-help@net.bio.net if you have problems.


IF YOU HAVE A PROBLEM:
----------------------

Please send a message to one of the following addresses depending upon
your location

Address                              Location
-------                              --------
biosci@daresbury.ac.uk               Europe, Africa, and Central Asia
biosci-help@net.bio.net              Americas and the Pacific Rim

and someone on the staff will help you.  PLEASE DO NOT send mail to
our personal e-mail addresses as this will delay a response to your
request for help.


How to post a message to the group:
-----------------------------------

If you use news, simply post a message into bionet.molbio.recombination.  Be
sure to set your "distribution" to "world" or else the message might
not leave your site!!

To post by e-mail, mail your message to one of the following addresses
depending upon your location:

Posting Address                      Location
---------------                      --------
recom@daresbury.ac.uk                Europe, Africa, and Central Asia
recom@net.bio.net                    Americas and the Pacific Rim

and your message will be distributed automatically to everyone on the
list and the USENET newsgroup.  There is no editorial intervention.

PLEASE DO NOT SEND SUBSCRIPTION REQUESTS TO THE POSTING ADDRESSES as
you will bother everyone on the newsgroup!!!


How to reply to a message on the group:
---------------------------------------

If you are using a newsreader, simply use the reply or follow-up
command on your newsreader (these vary from program to program) to
send either private or public replies.

If you are using e-mail, replies to messages that you receive will
*NOT* be automatically returned to the group.  This is the standard
for Internet mailing lists as opposed to BITNET LISTSERVs which often
send all replies back to everyone.  You must be certain that your
reply contains either of the two newsgroup posting addresses above in
your message header if you want to share it with everyone on the
group.  Otherwise in most cases your reply may go back to only the
original poster of the message to which you are replying.

ALWAYS be certain that you examine the address on your messages before
you send them!!!  Once a message is sent there is no way to cancel it
or bring it back!!!  Some non-Internet compliant mail systems may
attempt to send replies to our error-trapping address called
BIOSCI-REQUEST.  If yours does this, please be sure to readdress your
message to recom@net.bio.net or recom@daresbury.ac.uk if you want
to send it to the newsgroup.


How to look at archives of the list:
------------------------------------

The BIOSCI archives and other BIOSCI information can be found on our
WWW home page at URL http://www.bio.net/.  Easy access from the WWW
home page to our FTP/gopher area is available for information
retrieval.

Archives for RECOMBINATION/bionet.molbio.recombination are kept in the
anonymous FTP account at net.bio.net [204.31.212.2].  Look in the
directory pub/BIOSCI/RECOMBINATION for posting archives.  Each file
is assigned a date such as 9312 for December 1993.  Please note that
ours is a UNIX system and all file and directory names are
case-sensitive, i.e., upper case file names are different from lower
case names. 

You can also access these same files via Gopher if you start a gopher
session using net.bio.net as your gopher server.  Gopher also allows
you to view the individual messages within each monthly archive file.
The files are in the RECOMBINATION directory.  Postings to
bionet.molbio.recombination are also WAIS indexed and can be searched
via either gopher or WAIS at our site.  In gopher the option at
net.bio.net is "Search Bionet USENET Articles" and in WAIS one should
use the WAIS source biosci.src.  This is a WAIS index of all
BIOSCI/bionet messages including this newsgroup.  Please see the
BIOSCI FAQ for details.  The FAQ can be requested from
biosci-help@net.bio.net.

Once again, if you have any administrative questions that require
personal assistance, please address them to biosci-help@net.bio.net in
the U.S. or biosci@daresbury.ac.uk in the UK.

Best wishes for a successful newsgroup!

				Sincerely,

				Dave Kristofferson
				BIOSCI/bionet Manager

				biosci-help@net.bio.net

From owner-recombination@net.bio.net Tue Oct 17 23:00:00 1995
Path: biosci!internet!biosci!not-for-mail
From: biohelp (BIOSCI Administrator)
Newsgroups: bionet.molbio.recombination
Subject: IMPORTANT: BIOSCI miniFAQ
Date: 18 Oct 1995 02:02:10 -0700
Organization: BIOSCI International Newsgroups for Molecular Biology
Lines: 196
Sender: daemon@net.bio.net
Distribution: world
Message-ID: <199510180900.CAA27702@net.bio.net>
NNTP-Posting-Host: net.bio.net


This is a new "miniFAQ" designed to answer the questions that come up
the *most frequently*.  The main BIOSCI FAQ (Frequently Asked
Questions) is accessible on the World Wide Web at URL
http://www.bio.net/.

	Contents:
	--------
	1) What to do about "spams," i.e., junk mail, ads, etc.

	2) Examples of subscribing and unsubscribing to the mailing lists.

	3) How to access BIOSCI/bionet newsgroup archives.

	4) The BIOSCI user address and research interest directory.


1) What to do about "spams," i.e., junk mail, ads, etc.
-------------------------------------------------------
BIOSCI is a set of parallel USENET newsgroups (the "bionet" groups)
and mailing lists.  The same postings are distributed on both media
(except for a small number of mailing-list-only groups at
net.bio.net).  Unfortunately it is becoming a despicable practice on
the Internet (by a few people out to make a fast buck) to do automated
mass postings to thousands of newsgroups and mailing lists.  These
attempts to grab free advertising are refered to as "spams" in the
usual, somewhat boneheaded, net terminology.  USENET is more
susceptible to this practice, and many spams originate on the USENET
groups and then are passed on to the mailing lists.  However, spammers
also get lists of mailing addresses and hit these too, so neither
medium is immune.

What should you do personally if you get junk mail?
---------------------------------------------------
Just delete it and move on without reading it further.  Filing a
protest is becoming increasingly useless because spammers are often
disguising the addresses where the messages are sent from.  Unless you
really understand Internet mail systems, your attempt at protest by
sending replies to the message will often end up being sent to the
address of an innocent person that the spammer is victimizing.

What can BIOSCI/bionet do to protect its newsgroups?
----------------------------------------------------
The only solution currently available is to moderate the newsgroup.
If this newsgroup is already moderated, then you are in good shape.
Moderation protects the newsgroups from about 95% of the spams that
are being sent to date.  This means that someone has to take the time
to review each message before it goes out.  We have set up software
here that simply allows the moderator to forward to an address at
net.bio.net messages that (s)he wishes to have distributed.  This
takes no more time than that needed to read the message and pass it
on, say about 1 min. per message.

Most newsgroups currently have a discussion leader who is responsible
for their newsgroup.  The discussions leaders and their e-mail
addresses are listed in the BIOSCI Information Sheet which is
available on the Web at http://www.bio.net/.  If a newsgroup is being
hit with too many junk postings, please contact the discussion leader
for that group and see if there is interest in moderating the group.
Please do not assume that by simply posting a complaint to the
newsgroup itself, anyone on the BIOSCI staff will act on your
complaint.  With close to 100 newsgroups to run, the BIOSCI staff has
to rely on the discussion leaders of each newsgroup to report problems
directly to us at biosci-help@net.bio.net.

We will moderate any of our newsgroups if the discussion leader tells
us that the readership of the group wishes to do so and if a moderator
is willing to do the work.  For most BIOSCI/bionet groups, this
entails only a few minutes of work each day.

Moderating a newsgroup will resolve probably 95% of the junk postings.
Unfortunately there are easy ways for determined spammers to override
the moderation mechanism.  We are working on new systems to provide
access to our newsgroups over the WWW.  These should be available
soon, probably November 1995, and will allow you to use your Web
browser to look at the news postings.  While this will not stop
spammers from trying to post to the groups, this will give you yet
another way, besides using USENET news, to keep the junk out of your
personal mail files.


2) Examples of subscribing and unsubscribing to the mailing lists.
------------------------------------------------------------------
PLEASE NOTE: The BIOSCI management does NOT act on
subscription/unsubscription requests that are posted improperly to the
newsgroups and mailing lists.  People who do this only bother everyone
on the lists to no avail.  Please be sure to follow the proper
procedures below.

Gory details are in the BIOSCI Information sheets on the Web at
http://www.bio.net.  Below we give an example utilizing the
METHODS-AND-REAGENTS list at both of our two BIOSCI sites:

Users in the Americas and Pacific Rim countries who use the BIOSCI
------------------------------------------------------------------
node at computer net.bio.net:
----------------------------

A) Determine the "listname" which is the <=8 character mail address
                                         ^^^^^^^^^^^^^
   for the group.  These can be found in the BIOSCI Info. Sheet.  For
   the METHODS-AND-REAGENTS group the mailing address is
   methods@net.bio.net.  The listname is the portion of the address to
   the left of the @ sign, i.e., "methods".  The listname is used with
   the "subscribe" and "unsubscribe" commands illustrated below.

B) Mail all commands in the body of a mail message addressed to
   biosci-server@net.bio.net.  Do NOT send commands to the newsgroup
   posting addresses!  Leave the Subject: line blank, any text on it
   will be ignored.

C) In the body of your message put one or more of the following
   commands with an "end" command on the last line, e.g.,

   subscribe methods
   unsubscribe methods
   end

   Do NOT put your e-mail address or other text on these lines.  The
   server only allows you to cancel your subscription if the address
   on your mail header matches the address on our mailing list.
   Please ask for help at biosci-help@net.bio.net if your address has
   changed, e.g., if you know you are on the list but the server tells
   you that you are not a member.


Users in Europe, Africa, and Central Asia who use the BIOSCI node at
--------------------------------------------------------------------
computer daresbury.ac.uk (also known as dl.ac.uk):
-------------------------------------------------

To subscribe and unsubscribe to/from the BIOSCI lists, you need to
specify the full USENET newsgroup name with "bionet-news." prepended.
The USENET newsgroup names are listed in the BIOSCI Information sheet
on the Web at http://www.bio.net/.  For the METHODS-AND-REAGENTS list
the USENET newsgroup name is bionet.molbio.methds-reagnts, thus the
appropriate commands are

    sub bionet-news.bionet.molbio.methds-reagnts

    unsub bionet-news.bionet.molbio.methds-reagnts

These commands are included in a message addressed to mxt@dl.ac.uk,
NOT to the newsgroup mailing addresses.  As usual, include the text in
the body of the message as text on the Subject: line is ignored.

To unsubscribe from all the lists at the UK node, use

    unsub bionet-news

Please note that if the address in the list is different than the one
in your mail message header, you will not be able to unsubscribe by
this method. If you have problems, please mail biosci@daresbury.ac.uk.


3) How to access BIOSCI/bionet newsgroup archives.
--------------------------------------------------
Back postings of all BIOSCI/bionet newsgroups can be found on the
World Wide Web at URL http://www.bio.net/.  There are several
searchable newsgroup indices at this site.  E-mail users can search
the BIOSCI archives by using our waismail e-mail server.  For
instructions send the message

help

to waismail@net.bio.net.  Leave the Subject: line blank (anything
entered on the Subject: line is ignored).


4) The BIOSCI user address and research interest directory.
-----------------------------------------------------------
Please take this opportunity to add your name, address, and research
interest information to the BIOSCI User Address Database if you have
not already done so.

You can fill out the address form directly through our Web page at URL
http://www.bio.net/adrform.html.

The address database is reindexed nightly for WWW access (the URL is
http://www.bio.net/).  If you are not directly on the Internet but can
reach it by e-mail, please use our waismail server to access the user
directory.  waismail use is described above.  You can also request a
user address form by e-mail from biosci-help@net.bio.net.

Please check your database entry from time-to-time to see if your
address information is still up-to-date.  Because of our limited
personnel resources, we ask that you resubmit a *complete* form to
revise your entry; we only replace complete entries and do not have
resources to edit old forms.

				Sincerely,

				Dave Kristofferson
				BIOSCI/bionet Manager

				biosci-help@net.bio.net

From owner-recombination@net.bio.net Tue Oct 17 23:00:00 1995
Path: biosci!ATLAS.ODYSSEE.NET!dellaire
From: dellaire@ATLAS.ODYSSEE.NET (Dellaire, Graham)
Newsgroups: bionet.molbio.recombination
Subject: Welcome Everyone To RECOM!
Date: 18 Oct 1995 13:53:35 -0700
Organization: BIOSCI International Newsgroups for Molecular Biology
Lines: 121
Sender: daemon@net.bio.net
Distribution: world
Message-ID: <9510182049.AA20188@odyssee.net>
NNTP-Posting-Host: net.bio.net

**************************************************
-------------------WELCOME TO RECOM-----------------------

**************************************************

I would like to take this opportunity to welcome everyone to=20

bionet.molbio.recombination=20

Hence forth referred to as simply RECOM.


First of all I would like to thank everyone who has given input and
support for the  creation of this news group.  Particularly those in
in the beginning who lent their support and ideas and eventually their
vote!=7F

Opening comments

1. Participation is encouraged either by USENET or via e-mail=20

2. For those of you who do not have NEWS access (USENET  or BITNET
etc), it possible to subscribe to the list service for this news group.

A) to do this for North America and the Pacific Rim

send=20
to:biosci-server@net.bio.net
Subject: <leave blank>

<text body>

subscribe recom

<end of text body>

B) for Europe and the United Kingdom

send =20

to:MXT@dl.ac.uk
Subject: <leave blank>

<text body>

SUB bionet-news.bionet.molbio.recombination

<end of text body>


Although participation via USENET is perfectly fine on its own sometimes it
is much easier to receive the posts to this group directly to your e-mail.=
=20

3. All suggestions for the content of our discussion are welcome.

so far suggestions that may be adopted are as follows:

	a)Job Listing (post doc, Institution listings etc)

	b)Postings of concise editorials on given areas of participants
                        expertise
=09
	c)Postings of abstracts from recently published works or from
                        pre-prints where  applicable

	d)Postings of dates and sites of upcoming meetings
=09
	e)Posting of brief resumes of the events of the recent meetings.

	f)Posting of a recombination FAQ including:
		-reference lists for separate topics in recombination
                        	-lists of web resources (FTP,GOPHER etc) for
genetics and
                                        recombination
		-broad introductory sections on particular aspects of
                                       recombination to be contributed by
participants in the                                                 group.
		-news group charter
		-contact information for discussion leaders
		-perhaps posting of addresses of institutions that
                                        work in genetics as well as key
laboratories (Idealy we
would like to assemble a voluntary list of researchers and
there interest and addresses they can be reached at for
further discussion )




Please let us know what you think.  Together we can produce the type of news
forum that  can benefit both the novice and  veteran researcher alike.  The
direction that the new group takes is to be decided primarily by input from
the recombination community at large.  SO once again Let Us Know What You=
 Think!
=20


On behalf of myself and the other discussion leaders I wish to thank you
again for all your support,

Graham Dellaire
PrimaryDiscussion Leader
bionet.molbio.recombination

e-mail:dellaire@odyssee.net





********************************************************
Graham Dellaire                            Snail Mail
Div. of Experimental Medicine           Institute du Cancer de Montreal
Dept. of Medicine                               Louis Charles-Simard=20
McGill University                              1560 Sherbrooke Street E.
e-mail:dellaire@odyssee.net                Montreal, Quebec, Canada
or B2XE@musicb.mcgill.ca   =20
********************************************************



From owner-recombination@net.bio.net Tue Oct 17 23:00:00 1995
Path: biosci!ATLAS.ODYSSEE.NET!dellaire
From: dellaire@ATLAS.ODYSSEE.NET (Dellaire, Graham)
Newsgroups: bionet.molbio.recombination
Subject: Revised Charter for RECOM
Date: 18 Oct 1995 14:01:48 -0700
Organization: BIOSCI International Newsgroups for Molecular Biology
Lines: 147
Sender: daemon@net.bio.net
Distribution: world
Message-ID: <9510182057.AA20573@odyssee.net>
NNTP-Posting-Host: net.bio.net

*******************************************************
                                       RECOM
*******************************************************

Information on  RECOMBINATION/bionet.molbio.recombination

USENET newsgroup name:          bionet.molbio.recombination

Status: 			Unmoderated

One line description: 		Research on the recombination of DNA or RNA.

Mailing list name:     		RECOMBINATION

E-mail posting addresses:	recom@net.bio.net
                                recom@daresbury.ac.uk

Discussion leaders:

*Note: Area of expertise is written in brackets

Graham Dellaire,  e-mail dellaire@atlas.odyssee.net (b2xe@musicb.mcgill.ca)
Department of Medicine (Div. of Exp. Medicine)
McGill Univeristy,
Montreal, Quebec, Canada 
*(Genome Accessibility, Line-1 sequences, Gene Conversion and Ectopic Int.)


George Szatmari,  e-mail: szat@ere.umontreal.ca
Assistant Professor
Departement de Microbiologie et Immunologie
Universite de Montreal
CP 6128 Succursale Centre-Ville
Montreal, Quebec H3C 3J7
phone (514)343 5767  fax (514)343 5701
*(Site Specific Recombination Sytems)


Terry Chow e-mail: MDTY@musica.mcgill.ca
Associate Professor
Department of Oncology
Division of Radiation-Oncology
McGill University
Montreal General Hospital
1650 Ave. Cedar
Montreal, Quebec H3G 1A4
phone (514)934 8040 ext. 4179
fax (514)934 8220
*(Mammalian Genetics/gene therapy)


Dana Lasko e-mail: CZDL@musica.mcgill.ca
Assistant Professor of Medicine and Human Genetics
Project Director
Terry Fox Molecular Oncology Group
Lady Davis Institute for Medical Research
3755 Cote-Ste-Catherine Rd.
Montreal, PQ
Phone 340-8260 ext. 3454 (office and machine) or  ext. 5251 (lab)
Fax 340-7502
*(Replication and Recombination)



Charter:

The purpose of the RECOMBINATION newsgroup is to provide a proper
forum for the discussion of issues pertaining and involving recombination 
of DNA or RNA, in its many forms (see _Topics of Discussion_).  Primarily 
it should enable those researchers who work in recombination or aligned 
fields to communicate ideas and information, as well as, provide a chance 
for collaboration among national and international research groups.


Topics of Discussion include:
1. Gene conversion and ectopic integration 
2. Genome accessibility and nuclear/chromosome structure and recombination
                    -Matrix attachment sites (MARS)
                    -nucleosomes, histone 1 
                    -recombination hotspots
                    -fragile sites 
                    -origins of replication
3. Effect of DNA topology on recombination (Triple strand, Z-DNA, cruciform, 
bent etc)
4. Homologous recombination vs. nonhomologous or illegitimate 
                    -comparisons between bacterial, yeast and higher 
                        eukaryotic recombination  systems (ex. fungi, mammals) 
5. Models of recombination (One-end invasion, Double strand Break Repair, 
SSA etc)
6. Site-specific recombination systems (invertase, Cre and Flp recombinase 
etc)
7. Specific recombination systems in complex organisms
                    -VDJ recombination
                    -Antigenic variation and recombination (ex. 
                        trypanosomes, HIV, N.gonorrhea) 
                    -Yeast mating type locus 
8. Transcription and recombination 
9. DNA replication and recombination (ex. gene amplification (DHFR etc))
10. Evolution of the Genome
                    -retroposons (Line-1, Sine's), retroviruses and 
                        transposons
                    -formation of gene clusters and comparative mapping
                    -recombination between other repeat elements (alpha 
                        satellites, telomeres)
11. DNA repair systems and recombination (DSB and mismatch repair)
                    -including DNA repair deficient diseases (ex. Xoderma 
                        Pigmentosum)
12. Applications of recombination
                    -Gene therapy
                    -Transgenics and gene transfer
13. Viral diversity through RNA recombination
14. Population genetics and recombination:i.e. as a source of allelic 
        variation and as a measure of genetic exchange within and between
populations.

In addition this newsgroup provides:

        A forum for the exchange of information about future congresses
        and meetings in areas of molecular biology relating to recombination

        A forum for the exchange of information about textbooks, internet
        resources, visual materials, and computer programs.

        A source of quick help for last-minute troubleshooting, sources of 
        materials,
        and practical advice; in areas such as
                     -Vector design for transgene experiments
                     -Gene transfer techniques
                     -Animal models and cell lines
                     -Gene therapy protocols 


Subscribers are welcome.  Contributions within the functions outlined
above are encouraged.

The newsgroup is -UNMODERATED-.

********************************************************
Graham Dellaire                            Snail Mail
Div. of Experimental Medicine           Institute du Cancer de Montreal
Dept. of Medicine                               Louis Charles-Simard 
McGill University                              1560 Sherbrooke Street E.
e-mail:dellaire@odyssee.net                Montreal, Quebec, Canada
or B2XE@musicb.mcgill.ca    
********************************************************



From owner-recombination@net.bio.net Tue Oct 17 23:00:00 1995
Newsgroups: bionet.molbio.recombination
Path: biosci!lhc.nlm.nih.gov!nih-csl!NewsWatcher!user
From: lichten@helix.nih.gov (Michael Lichten)
Subject: Abstract posting
Message-ID: <lichten-1810950929470001@128.231.218.92>
Sender: postman@alw.nih.gov (AMDS Postmaster)
Nntp-Posting-Host: 128.231.218.92
Organization: LB/DCBDC/NCI
Date: Wed, 18 Oct 1995 13:29:47 GMT
Lines: 7

I would like to propose that this newsgroup be used for posting abstracts
of papers submitted for publication.  Anyone else have any feelings on
this matter?

-- 
Michael Lichten
lichten@helix.nih.gov

From owner-recombination@net.bio.net Thu Oct 19 23:00:00 1995
Path: biosci!VAXA.CIS.UWOSH.EDU!lansman
From: lansman@VAXA.CIS.UWOSH.EDU (Bob Lansman)
Newsgroups: bionet.molbio.recombination
Subject: Alu sequences as portable regions of homology
Date: 20 Oct 1995 11:37:22 -0700
Organization: BIOSCI International Newsgroups for Molecular Biology
Lines: 12
Sender: daemon@net.bio.net
Distribution: world
Message-ID: <01HWNY9PZMCI00EDPO@VAXA.CIS.UWOSH.EDU>
NNTP-Posting-Host: net.bio.net

At a symposium this summer, Richard Fishel, of the University of Vermont,
made the statement that, in cells with fully functional mismatch repair,
recombination between heterologous Alu sequence is inhibited by lack of
complete homology. But, this type of recombination can occur in tumor cells,
in which mutation in genes like MSH has disabled mismatch repair.  Does
anyone have references to work which would support these statments?  Does
anyone have comments regarding the general acceptance of these ideas?  I
have always thought that recombination between Alus in different chromosomal
locations was a likely cause of chromosome rearrangements during evolution,
such as the duplication of beta-like globin genes.  Is this not a widely
accepted model?  


From owner-recombination@net.bio.net Thu Oct 19 23:00:00 1995
Newsgroups: bionet.molbio.recombination
Path: biosci!lhc.nlm.nih.gov!nih-csl!NewsWatcher!user
From: lichten@helix.nih.gov (Michael Lichten)
Subject: Re: Alu sequences as portable regions of homology
Message-ID: <lichten-2010951735240001@128.231.218.92>
Sender: postman@alw.nih.gov (AMDS Postmaster)
Nntp-Posting-Host: 128.231.218.92
Organization: LB/DCBDC/NCI
References: <01HWNY9PZMCI00EDPO@VAXA.CIS.UWOSH.EDU>
Date: Fri, 20 Oct 1995 21:35:24 GMT
Lines: 37

In article <01HWNY9PZMCI00EDPO@VAXA.CIS.UWOSH.EDU>,
lansman@VAXA.CIS.UWOSH.EDU (Bob Lansman) wrote:

> At a symposium this summer, Richard Fishel, of the University of Vermont,
> made the statement that, in cells with fully functional mismatch repair,
> recombination between heterologous Alu sequence is inhibited by lack of
> complete homology. But, this type of recombination can occur in tumor cells,
> in which mutation in genes like MSH has disabled mismatch repair.  Does
> anyone have references to work which would support these statments?

I think Rick was running with the ball a bit.  It is becoming increasingly
apparent that mismatch repair functions do inhibit recombination between
diverged sequences; however, the small size of Alus may preclude their
efficient use for recombination irrespective of their degree of
divergence.  

>  Does
> anyone have comments regarding the general acceptance of these ideas?  I
> have always thought that recombination between Alus in different chromosomal
> locations was a likely cause of chromosome rearrangements during evolution,
> such as the duplication of beta-like globin genes.  Is this not a widely
> accepted model? 

Most chromosome rearrangements examined in mammals that I know of
(admittedly, biased towards those found in tumors) don't appear to occur
at blocks of homology.  HOWEVER, this is not to say it can't happen.  In
fact, John Schimenti has some very provocative evidence that ectopic gene
conversion can happen at a very high frequency in the mouse male germ
line.  

My lab has been studying ectopic recombination of this sort in
Saccharomyces, and I'll post an abstract describing this work as soon as
the paper is finished.

-- 
Michael Lichten
lichten@helix.nih.gov

From owner-recombination@net.bio.net Thu Oct 19 23:00:00 1995
Path: biosci!ATLAS.ODYSSEE.NET!dellaire
From: dellaire@ATLAS.ODYSSEE.NET (Dellaire, Graham)
Newsgroups: bionet.molbio.recombination
Subject: Re: RECOMBINATION/bionet.molbio.recombination is ready!
Date: 20 Oct 1995 14:36:34 -0700
Organization: BIOSCI International Newsgroups for Molecular Biology
Lines: 64
Sender: daemon@net.bio.net
Distribution: world
Message-ID: <9510202133.AA01982@odyssee.net>
NNTP-Posting-Host: net.bio.net

>In Article <468aog$se0@epervier.CC.UMontreal.CA>, szat@ERE.UMontreal.CA
>(Szatmari George) wrote:
>
>[snip]
>
>>I'd like to start things rolling by posing a question about yeast.
>>Why are yeast (notably S. cerevisiae) so recombinogenic, when
>>higher eukaryotes and prokaryotes are not?  Is this due to a more
>>active recA-like protein (or proteins)?  Or is it something
>>totally different?
>
>Could it be that a mistake in recombination in a unicellular organism only
>risks itself (the cells dies), while in a multicellular organism, a mistake
>in recombination risks the entire organism (tumor - organism 10E6-10E9 cells
>die)?
>
>Brian D. Halligan                halligan@post.its.mcw.edu

I think it may be inpart the fact that Yeast lacks one of the most important
Histones from an accessibility point of view...H1..

It is well know that when you remove H1 you get different DNaseI parterns
which indicates a change in accessibility of the DNA.  Therefore DNA is
going to be less compact in Yeast than in mammalian cells and  more
accessible to recombination and enzymes that may promote recombination (Topo
I+ II, DnaseI etc.).

Secondly,  homologous recombination is very efficient in Yeast and not so
efficient (if we can even use the word effecient in the same context as
mammalian homologous recombination) in mammals.  On the other hand the
reverse is true.  Mammalian cells are extremely efficient at illegitimate
nonhomologous recombination and Yeast are pitiful in this respect.  Perhaps
these two differences are derived most basically from the fact that we as
mammals are multicellular and yeast are not.  When we have a break in our
DNA our cells try to fix it as fast as possible... DNA free ends=death for
most cells.  In yeast this is not such a necessity if the cell dies it is
only one of millions or billions in a colony and because of a quick
generation time even if one cell survives from a colony with in three days
you have another colony.  If many of your cells die, particularly in an
organ such as the liver or heart... the whole organism dies.  This leads
into more efficient homologous recombination in Yeast.  We know that if
homolgous recombination was very active in mammalian cells (to the level it
is in yeast)  your cells would accumulate horrible genome rearrangments in
no time.  This could occur by simple cross over say between histone genes or
ribosomal rna's etc, never mind the 100,000 or so Line-1 sequences or
~500,000 alu's!  

Thus it makes sense that in mammalian cells homologous recombination is much
less efficient than yeast. Now as why Yeast are more recombinogenic than
bacteria... that is open as  frankly I haven't the faintest idea where to begin.

Graham Dellaire

>
********************************************************
Graham Dellaire                            Snail Mail
Div. of Experimental Medicine           Institute du Cancer de Montreal
Dept. of Medicine                               Louis Charles-Simard 
McGill University                              1560 Sherbrooke Street E.
e-mail:dellaire@odyssee.net                Montreal, Quebec, Canada
or B2XE@musicb.mcgill.ca    
********************************************************



From owner-recombination@net.bio.net Thu Oct 19 23:00:00 1995
Path: biosci!ATLAS.ODYSSEE.NET!dellaire
From: dellaire@ATLAS.ODYSSEE.NET (Dellaire, Graham)
Newsgroups: bionet.molbio.recombination
Subject: Re: Alu sequences as portable regions of homology
Date: 20 Oct 1995 14:18:00 -0700
Organization: BIOSCI International Newsgroups for Molecular Biology
Lines: 68
Sender: daemon@net.bio.net
Distribution: world
Message-ID: <9510202115.AA00970@odyssee.net>
NNTP-Posting-Host: net.bio.net

>At a symposium this summer, Richard Fishel, of the University of Vermont,
>made the statement that, in cells with fully functional mismatch repair,
>recombination between heterologous Alu sequence is inhibited by lack of
>complete homology. But, this type of recombination can occur in tumor cells,
>in which mutation in genes like MSH has disabled mismatch repair.  Does
>anyone have references to work which would support these statments?  Does
>anyone have comments regarding the general acceptance of these ideas?  I
>have always thought that recombination between Alus in different chromosomal
>locations was a likely cause of chromosome rearrangements during evolution,
>such as the duplication of beta-like globin genes.  Is this not a widely
>accepted model?  
>
The "Homeology" affects the migration of cross overs through homology  very
strongly and therefore inhibits gene conversion and shunts the recombination
intermediate to another non integrative (non crossover) pathway.    The
result is a net drop in exchange between regions that are not 100%
homologous as in Line-1 elements and Alu's.
So goes the current hypotheses

In my lab in (I work with Pierre Chartrand) they have done much work with
Line-1 elements... there are some interesting papers by A. Belamaaza et al. and 
J. F.Villemure et al. that address the topic of homeology and  recombination
and they suggest reasons (including mismatch repair) for the apparent
inhibition of cross over
between regions that are homeologous.  I believe both papers are in MCB
(Villemure is 95 and the other is 94 or 93)  If you do a medline for these
authors you should find their papers easily.

I will try to get the exact references if you wish but it will be Monday or
later.


To address the embryonic question.  In the case of line-1's there is
evidence that they are active as retroposons during embryogenesis.
Supposedly the putative transposase found in full length Line's is
transcribed in embryonic cells.  Therefore you can invision integration of
these elements once reverse transcribed into functional genes and disrupting
them.  Also in embryonic cells  there is evidence that the genome is more
open... ie. more genes are transcribable, more replication origins may be
firing or in use (you need to rapidly duplicate cells in early development
say from one cell to full blastula in 8 days) and
hence probably more recombination.  Just think of the DNA looping folding
being cut by topoisomerases and gyrases etc to eleviate all the strain from
replication and transcription and you are bound to have a stray end of DNA
available for recombination.  It may be that DNA mismatch system is
saturated at this point (or perhaps are all DNA repair mechanisms) just by
the shear number of mistakes occurring during this rapid burst of growth,
and you then get stray exchanges of DNA between ALu's and line's.  These
exchanges do happen often enough such that quite a few hereditary disease
can be ascribed to insertion of retroposable elements in functional genes.
The Beta Globin locus is particularly recombinogenic and perhaps this is
again (like in the embryo)  linked to accessibility of the DNA because of
high transcription rates and the fact that I believe there is a origin of
replication linked to this locus.



Graham Dellaire
********************************************************
Graham Dellaire                            Snail Mail
Div. of Experimental Medicine           Institute du Cancer de Montreal
Dept. of Medicine                               Louis Charles-Simard 
McGill University                              1560 Sherbrooke Street E.
e-mail:dellaire@odyssee.net                Montreal, Quebec, Canada
or B2XE@musicb.mcgill.ca    
********************************************************



From owner-recombination@net.bio.net Thu Oct 19 23:00:00 1995
Path: biosci!bdg10.niddk.nih.gov!KAYUWEW
From: KAYUWEW@bdg10.niddk.nih.gov ("WAGNER, KAY-UWE")
Newsgroups: bionet.molbio.recombination
Subject: (none)
Date: 20 Oct 1995 16:59:55 -0700
Organization: BIOSCI International Newsgroups for Molecular Biology
Lines: 1
Sender: daemon@net.bio.net
Distribution: world
Message-ID: <308837B1@SMTP2.mm.hub.nih.gov>
NNTP-Posting-Host: net.bio.net

Who has antibodies for Cre recombinase?

From owner-recombination@net.bio.net Thu Oct 19 23:00:00 1995
Path: biosci!agate!howland.reston.ans.net!newsfeed.internetmci.com!chi-news.cic.net!uwm.edu!post.its.mcw.edu!post!halligan
From: halligan@post.its.mcw.edu (Brian Halligan)
Newsgroups: bionet.molbio.recombination
Subject: Re: RECOMBINATION/bionet.molbio.recombination is ready!
Date: Fri, 20 Oct 95 18:46:43 GMT
Organization: Department of Microbiology, Medical College of Wisconsin
Lines: 20
Distribution: world
Message-ID: <halligan.1164602443A@post.its.mcw.edu>
References: <45v661$lqr@net.bio.net> <468aog$se0@epervier.CC.UMontreal.CA>
NNTP-Posting-Host: d256-1.microb.mcw.edu
X-Newsreader: VersaTerm Link v1.1.1

In Article <468aog$se0@epervier.CC.UMontreal.CA>, szat@ERE.UMontreal.CA
(Szatmari George) wrote:

[snip]

>I'd like to start things rolling by posing a question about yeast.
>Why are yeast (notably S. cerevisiae) so recombinogenic, when
>higher eukaryotes and prokaryotes are not?  Is this due to a more
>active recA-like protein (or proteins)?  Or is it something
>totally different?

Could it be that a mistake in recombination in a unicellular organism only
risks itself (the cells dies), while in a multicellular organism, a mistake
in recombination risks the entire organism (tumor - organism 10E6-10E9 cells
die)?

Brian D. Halligan                halligan@post.its.mcw.edu
Assistant Professor              414-456-8413 (voice)
Department of Microbiology       414-266-8522 (FAX)
Medical College of Wisconsin

From owner-recombination@net.bio.net Fri Oct 20 23:00:00 1995
Newsgroups: bionet.molbio.recombination
Path: biosci!lhc.nlm.nih.gov!nih-csl!NewsWatcher!user
From: lichten@helix.nih.gov (Michael Lichten)
Subject: Re: Alternative mech. to resolve Holliday junctions?
Message-ID: <lichten-2110951603420001@128.231.218.92>
Sender: postman@alw.nih.gov (AMDS Postmaster)
Nntp-Posting-Host: 128.231.218.92
Organization: LB/DCBDC/NCI
References: <468a8r$ssk@news.duke.edu>
Date: Sat, 21 Oct 1995 20:03:42 GMT
Lines: 24

In article <468a8r$ssk@news.duke.edu>, djt@rpiv.mc.duke.edu (Dan Tomso) wrote:

> Greetings.
>         I'd like to collect information on alternative mechanisms for 
> resolving Holliday junctions.  By 'alternative,' I mean mechanisms which 
> don't involve a specific resolvase activity.  I'm working in a system 
> (T4) where a lot of recombination can occur even in resolvase mutants 
> (endo VII mutants), and I'm wondering what the mechanisms of resolution 
> might be.

1.  Replication.  Makes 2 parental and 2 recombined molecules  
2.  Branch migration to two nick at the same place on the appropriate
strands (not very likely, huh?)
3.  Branch migration to a nick in one of the crossing strands.  Turns the
junction into two replicating forks.

1 and 3 have pretty dire consequences for a chromosomal organism but for
bacteriophage such as T4 or lambda that just need a unit lenght + a bit
genome to be packaged, I think it's likely that these strategies are often
used.

-- 
Michael Lichten
lichten@helix.nih.gov

From owner-recombination@net.bio.net Fri Oct 20 23:00:00 1995
Path: biosci!agate!dog.ee.lbl.gov!news.cs.utah.edu!cs.utexas.edu!uunet!in2.uu.net!solaris.cc.vt.edu!news.duke.edu!rpiv.mc.duke.edu!djt
From: djt@rpiv.mc.duke.edu (Dan Tomso)
Newsgroups: bionet.molbio.recombination
Subject: Alternative mech. to resolve Holliday junctions?
Date: 20 Oct 1995 14:04:11 GMT
Organization: Duke University, Durham, NC, USA
Lines: 13
Message-ID: <468a8r$ssk@news.duke.edu>
NNTP-Posting-Host: rpiv.mc.duke.edu
X-Newsreader: TIN [version 1.2 PL2]

Greetings.
	I'd like to collect information on alternative mechanisms for 
resolving Holliday junctions.  By 'alternative,' I mean mechanisms which 
don't involve a specific resolvase activity.  I'm working in a system 
(T4) where a lot of recombination can occur even in resolvase mutants 
(endo VII mutants), and I'm wondering what the mechanisms of resolution 
might be.
	I'm also curious as to just how large the readership for this 
newsgroup is.  Hopefully, this thread will spawn some discussion and let 
me survey (passively) the participants at the same time.

				Dan Tomso
				

From owner-recombination@net.bio.net Fri Oct 20 23:00:00 1995
Newsgroups: bionet.molbio.recombination
Path: biosci!agate!howland.reston.ans.net!newsfeed.internetmci.com!uunet!in1.uu.net!nih-csl!NewsWatcher!user
From: lichten@helix.nih.gov (Michael Lichten)
Subject: Re: RECOMBINATION/bionet.molbio.recombination is ready!
Message-ID: <lichten-2110951556040001@128.231.218.92>
Sender: postman@alw.nih.gov (AMDS Postmaster)
Nntp-Posting-Host: 128.231.218.92
Organization: LB/DCBDC/NCI
References: <9510202133.AA01982@odyssee.net>
Date: Sat, 21 Oct 1995 19:56:04 GMT
Lines: 22

In article <9510202133.AA01982@odyssee.net>, dellaire@ATLAS.ODYSSEE.NET
(Dellaire, Graham) wrote:

> Secondly,  homologous recombination is very efficient in Yeast and not so
> efficient (if we can even use the word effecient in the same context as
> mammalian homologous recombination) in mammals.  On the other hand the
> reverse is true.  Mammalian cells are extremely efficient at illegitimate
> nonhomologous recombination and Yeast are pitiful in this respect.  

Is this really true?  What's the efficiency at which mammalian cells
repair joints illegitimately--on a per break basis?  Is it really that
efficient?  Let's come up with some numbers before we start speculating as
to whether a single death in a colony is worse than a single death in a
liver!  My guess is that no one really knows what the efficiency of break
repair is in mammalian cells.  Transfection experiments don't count--an I
think that everyone in this thread is basing their conclusions on those
experiments.  Give me an experiment in which the efficiency of recovery is
given in terms of input molecules, please.

-- 
Michael Lichten
lichten@helix.nih.gov

From owner-recombination@net.bio.net Fri Oct 20 23:00:00 1995
Path: biosci!ATLAS.ODYSSEE.NET!dellaire
From: dellaire@ATLAS.ODYSSEE.NET (Dellaire, Graham)
Newsgroups: bionet.molbio.recombination
Subject: Re:Yeast Vs. Mammalian cells con't
Date: 21 Oct 1995 15:54:20 -0700
Organization: BIOSCI International Newsgroups for Molecular Biology
Lines: 116
Sender: daemon@net.bio.net
Distribution: world
Message-ID: <9510212251.AA06092@odyssee.net>
NNTP-Posting-Host: net.bio.net

>In article <9510202133.AA01982@odyssee.net>, dellaire@ATLAS.ODYSSEE.NET
>(Dellaire, Graham) wrote:
>
>> Secondly,  homologous recombination is very efficient in Yeast and not so
>> efficient (if we can even use the word effecient in the same context as
>> mammalian homologous recombination) in mammals.  On the other hand the
>> reverse is true.  Mammalian cells are extremely efficient at illegitimate
>> nonhomologous recombination and Yeast are pitiful in this respect.  
>
>Is this really true?  What's the efficiency at which mammalian cells
>repair joints illegitimately--on a per break basis? Is it really that
>efficient? 


Okay from personal experience homologous recombination in my hands is 
very inefficient in comparison to illegitimate recombination.  For example
using the same construct I can get one targeted event in 500,000 cells (ie.
one clone after selection for a reconstituted marker)  using calcium
phosphate transfection with ~20 ug of DNA ( for LTA murine fibroblasts.).
Now when I select for illegitimate events... I get on average ~700 to 1000
clones.  Even though many events are not counted because they fail to
produce  a selectable gene product (integrated in heterochromatin what have
you) you can assume for all intents and purposese that the numbers are
relative.  So from my point of view in LTA's illegitimate recombination
(reflected by the number of cells that have integrated a construct and
produced a selectable marker) is much more efficient than homologous
recombination. Three logs more efficient.  I see a  similar ratio with
electropration. 

Now I do not see homology driven events if they do not result in the
reconstitution of my selectable gene.  So one could argue that the actual
homologous recombination is higher than measured.  It has not been  proven
that illegitimate events do not first involve some sort of homology search,
in fact my current thesis project aims to shed some light on  this.  But on
the most basic level from transfection experiments it seems that
illegitimate events (as measured by integration and expression of a
selectable gene) are more common than targeted events. 

As far as efficiency of recombination on a per break basis this would be
hard to measure.   It is hard to determine the amount of DNA that enters
each cell in any given transfection method.   For most transfection methods
the mode of DNA entry into the nucleus has not been sufficiently determined.
So one, you can't measure the amount of DNA your cells took up and secondly,
you don't know how much of the DNA made it into the nucleus and finally, you
don't know when the DNA was integrated.  All of this makes it hard to
calculate the number of envents per break.

On top of this as discussed above you have a bias for events that produce a
functional selection gene that has integrated in the genome at a site where
it is expressed.    


> Let's come up with some numbers before we start speculating as
>to whether a single death in a colony is worse than a single death in a
>liver!  My guess is that no one really knows what the efficiency of break
>repair is in mammalian cells.  Transfection experiments don't count--an I
>think that everyone in this thread is basing their conclusions on those
>experiments.

Okay if you look at one somatic cell it may not be such a big deal at first
glance. Cells die all the time particularly in the epithelia and the
organism is not adversly affected.  If this rearrangement leads to a tumor
cell phenotype it is a different story.  Secondly if you assume that a
rearrangement would be able to occur in embryonic cells the death of a
precursor cell (basis of fate mapping) could have severe effects on the
organism.  Missing limbs etc.  Yeast do not have such complexities to worry
about.  A rearrangement in a hemopoietic myleogenic precursor (say something
like the bcr/abl rearrangement) can lead to leukemias that can kill the
organism regardless of whether the rest of the cells in the organism are
functioning well.  

I think this is more clear now as to the point I was trying to make.   Yeast
in a colony don't have to worry about maintaining complex systems (such as
organs) and the level of development in higher eukaryotes is much
greater...hence there  is more  pressure to have cells divide correctly and
maintain there genomic integrity in multicellular complex organisms.    

Another particularly interesting aspect to this is the number of
introns..... yeast have a paucity and mammalian cells have a plethora.
Perhaps this is a mechanism to minimize the damage of rearrangements in
complex organisms.  The more extraneous non coding material the less chance
of a rearrangement ablating a gene function.  

  > Give me an experiment in which the efficiency of recovery is
>given in terms of input molecules, please.
>

>Michael Lichten
>lichten@helix.nih.gov


AS discussed above this is hard if not nearly impossible to do with current 
transfection protocols (sucha as CaPO4, electroporation or lipofection) as
you can not be 100 percent certain of the amount of DNA that is taken up by
any given cell. 
Microinjection may be a different story...

I know in Xenopus you can inject nuclei with Linear DNA and in this way you 
know the number of input molecules.  In Xenopus the end-end  joining
(illegitimate recombination) is very effecient.  I am sure there must be a
similar experiment with mammalian cells, if there isn't it should be simple
enough to do.



Graham Dellaire
********************************************************
Graham Dellaire                            Snail Mail
Div. of Experimental Medicine           Institute du Cancer de Montreal
Dept. of Medicine                               Louis Charles-Simard 
McGill University                              1560 Sherbrooke Street E.
e-mail:dellaire@odyssee.net                Montreal, Quebec, Canada
or B2XE@musicb.mcgill.ca    
********************************************************



From owner-recombination@net.bio.net Sat Oct 21 23:00:00 1995
Path: biosci!agate!news.ucdavis.edu!rocky.ucdavis.edu!ez020665
From: WOOKIE <ez020665@peseta.ucdavis.edu>
Newsgroups: bionet.molbio.recombination
Subject: Other newsgroups like this?
Date: Sat, 21 Oct 1995 20:17:00 -0700
Organization: University of California, Davis
Lines: 2
Message-ID: <Pine.SOL.3.91.951021201611.2090A-100000@rocky.ucdavis.edu>
NNTP-Posting-Host: rocky.ucdavis.edu
Mime-Version: 1.0
Content-Type: TEXT/PLAIN; charset=US-ASCII
X-Sender: ez020665@rocky.ucdavis.edu

Does anyone know of any other newsgroups like this one?
rich

From owner-recombination@net.bio.net Sat Oct 21 23:00:00 1995
Path: biosci!agate!news.ucdavis.edu!boris.ucdavis.edu!fznewt
From: Jeff 'Newt' Sekelsky <fznewt@peseta.ucdavis.edu>
Newsgroups: bionet.molbio.recombination
Subject: Re: Alternative mech. to resolve Holliday junctions?
Date: Sun, 22 Oct 1995 16:31:07 -0700
Organization: University of California, Davis
Lines: 23
Message-ID: <Pine.SOL.3.91.951022160259.27947A-100000@boris.ucdavis.edu>
NNTP-Posting-Host: boris.ucdavis.edu
Mime-Version: 1.0
Content-Type: TEXT/PLAIN; charset=US-ASCII
X-Sender: fznewt@boris.ucdavis.edu
In-Reply-To: <468a8r$ssk@news.duke.edu> 

On 20 Oct 1995, Dan Tomso wrote:

> Greetings.
> 	I'd like to collect information on alternative mechanisms for 
> resolving Holliday junctions.  By 'alternative,' I mean mechanisms which 
> don't involve a specific resolvase activity.  I'm working in a system 
> (T4) where a lot of recombination can occur even in resolvase mutants 
> (endo VII mutants), and I'm wondering what the mechanisms of resolution 
> might be.
> 	I'm also curious as to just how large the readership for this 
> newsgroup is.  Hopefully, this thread will spawn some discussion and let 
> me survey (passively) the participants at the same time.
> 
> 				Dan Tomso
> 				
> 
For an even number of Holliday junctions (e.g. the double Holliday 
junction intermediate in the double-strand break repair model of 
recombination), Thaler, Stahl, and Stahl (1987, Genetics 116: 501)
suggested that resolution can occur without resolvase by the unwinding
activity of a topoisomerase.

Jeff Sekelsky

From owner-recombination@net.bio.net Sat Oct 21 23:00:00 1995
Path: biosci!CS.Arizona.EDU!uunet!in2.uu.net!newsflash.concordia.ca!feed.umontreal.ca!szat
From: szat@ERE.UMontreal.CA (Szatmari George)
Newsgroups: bionet.molbio.recombination
Subject: Re: RECOMBINATION/bionet.molbio.recombination is ready!
Date: 20 Oct 1995 14:12:32 GMT
Organization: Universite de Montreal
Lines: 15
Distribution: world
Message-ID: <468aog$se0@epervier.CC.UMontreal.CA>
References: <45v661$lqr@net.bio.net>
NNTP-Posting-Host: alize.ere.umontreal.ca

Dear readers,

Thanks to all who voted "yes" to the formation of this newsgroup.
I'm looking forward to many fruitful discussions about recombination.

I'd like to start things rolling by posing a question about yeast.
Why are yeast (notably S. cerevisiae) so recombinogenic, when
higher eukaryotes and prokaryotes are not?  Is this due to a more
active recA-like protein (or proteins)?  Or is it something
totally different?

George Szatmari
(just a bacterial mol. biologist)
Dept de microbiologie, Univ de Montreal


From owner-recombination@net.bio.net Tue Oct 24 22:00:00 1995
Path: biosci!CS.Arizona.EDU!uunet!in1.uu.net!usenet.eel.ufl.edu!newsfeed.internetmci.com!howland.reston.ans.net!agate!news.duke.edu!rpiv.mc.duke.edu!djt
From: djt@rpiv.mc.duke.edu (Dan Tomso)
Newsgroups: bionet.molbio.recombination
Subject: Re: RECOMBINATION/bionet.molbio.recombination is ready!
Date: 23 Oct 1995 02:28:49 GMT
Organization: Duke University, Durham, NC, USA
Lines: 46
Distribution: world
Message-ID: <46eul1$r92@news.duke.edu>
References: <45v661$lqr@net.bio.net> <468aog$se0@epervier.CC.UMontreal.CA>
NNTP-Posting-Host: rpiv.mc.duke.edu
X-Newsreader: TIN [version 1.2 PL2]

Greetings.
	I have a few comments (and questions) on this:

Szatmari George (szat@ERE.UMontreal.CA) wrote:

: I'd like to start things rolling by posing a question about yeast.
: Why are yeast (notably S. cerevisiae) so recombinogenic, when
: higher eukaryotes and prokaryotes are not?
	Most of the followup on this thread (which I have omitted for 
brevity) seems to revolve around this question:  Is yeast really more 
recombinogenic, or do we just lack an adequate measure for meaningful 
comparison?  It seems that transfection assays are not necessarily the 
best measure, since they ask for a lot of things to happen:  DNA must 
enter the cells, find its homologue in a very large genome, and recombine 
in such a way as to produce a viable cell.  I'm not sure what the right 
question to ask is, but here are some things that I am curious about:

How do the frequencies of meiotic recombination events (e.g. gene 
conversion) compare between S. cerevisiae and, say, Drosophila?

Have any experiments been done in mammalian or other euk. cells with 
defined substrates capable of undergoing 'internal' recombination (e.g. 
plasmids with 2 homologous segments).  These kinds of experiments have 
been used extensively in yeast and bacterial sytems to measure all sorts 
of recombination events.  You can often measure recombination directly, 
with a physical assay (Southern blotting).  Something like this might 
simplify comparisons.  I seem to remember seeing something like this in a 
recent issue of Genetics.

	Incidentally, I can think of a few organisms with recombination 
'machinery' that is really impressive.  Phage T4 (where I spend my days) 
shows recombination frequencies as high as 10% per 1000 bases, which 
means that markers as close as 5 kb assort almost independently.
	Another fun one is D. radiodurans, which I believe came to the
attention of the field when it was cultured from a can of spoiled meat
that had been (supposedly) gamma ray sterilized.  I recall seeing an
abstract that suggested this species can survive upwards of 150 double
strand breaks.
	I really have no point to make with regard to these last two
observations, other than to express general fascination with the mystery
of recombination.  Also, I suppose, I felt slighted when yeast was
described as 'more recombinogenic' in an unqualified way. :)  Why one
organism should be more recombinogenic than another is a difficult
question to address, especially without a convenient approach to
'cross-platform' experimentation. 
	

From owner-recombination@net.bio.net Thu Oct 26 22:00:00 1995
Path: biosci!agate!news.Stanford.EDU!NewsWatcher!user
From: schreibr@cmgm.stanford.edu (Edgar Schreiber)
Newsgroups: bionet.molbio.recombination
Subject: optimization for generating recombinant Adenoviruses
Followup-To: bionet.molbio.recombination
Date: 26 Oct 1995 03:53:48 GMT
Organization: Stanford University
Lines: 7
Message-ID: <schreibr-251095195318@36.173.0.149>
NNTP-Posting-Host: tip-mp8-ncs-6.stanford.edu

I would appreciate any comments and protocols that are  helpful to enhance
the frequency of plasmid to plasmid recombination in mammalian 293 cells
for the generation of recombinant Adenoviruses. Is electroporation more
"recombinogenic" than CaPO transfection ?
Thank you
Edgar
schreibr@cmgm.stanford.edu

From owner-recombination@net.bio.net Thu Oct 26 22:00:00 1995
Path: biosci!news.Stanford.EDU!agate!dog.ee.lbl.gov!news.cs.utah.edu!cs.utexas.edu!swrinde!howland.reston.ans.net!vixen.cso.uiuc.edu!newsrelay.iastate.edu!news.iastate.edu!usenet
From: "Patrick S. Schnable" <schnable@iastate.edu>
Newsgroups: bionet.molbio.recombination
Subject: abstract from Dec Issue of The Plant Cell
Date: 25 Oct 1995 14:59:42 GMT
Organization: Iowa State Univ
Lines: 22
Message-ID: <46ljcu$c4t@news.iastate.edu>
NNTP-Posting-Host: pc2696.agron.iastate.edu
Mime-Version: 1.0
Content-Type: text/plain; charset=iso-8859-1
Content-Transfer-Encoding: 8bit
X-Mailer: Mozilla 1.1N (Macintosh; I; 68K)
X-URL: news:bionet.molbio.recombination

I liked Michael Lichten's idea to post recombination abstracts here. I'll start 
the ball rolling with:

Xu XJ, A-P Hsia, L Zhang, BJ Nikolau, PS Schnable (1995) Meiotic recombination 
breakpoints resolve at high rates at the 5¹ end of a maize coding sequence.  
Plant Cell, in press (scheduled for the December issue).  

Sequence analysis of recombination break points has defined a 377-bp 
recombination hot spot within the anthocyanin1 (a1) gene.  One-fifth of all 
recombination events that occurred within the 140-kb a1-shrunken2 (sh2) interval 
resolved within this 377-bp hot spot.  In yeast, meiotic double-strand breaks in 
chromosomal DNA are thought to initiate recombination and are generally located 
5¹ of coding regions, near transcription promoter sequences.  Because the a1 
recombination hot spot is located within the 5¹ transcribed region of the a1 
gene, the sites at which recombination events initiate and resolve appear to be 
different, but both appear to be regulated in relation to transcribed sequences.  
Although transposon insertions are known to suppress recombination and alter the 
ratio of crossovers to apparent gene conversions, the Mutator1 (Mu1) transposon 
insertion in the a1-mum2 allele does not alter the sites at which recombination 
events resolve.



From owner-recombination@net.bio.net Thu Oct 26 22:00:00 1995
Path: biosci!dh.com!bkatz
From: bkatz@dh.com (Boris Katz)
Newsgroups: bionet.molbio.recombination
Subject: subscribe RECOMBINATION
Date: 26 Oct 1995 20:43:21 -0700
Organization: BIOSCI International Newsgroups for Molecular Biology
Lines: 1
Sender: daemon@net.bio.net
Distribution: world
Message-ID: <bkatz.186.0048FC5E@dh.com>

sibscribe RECOMBINATION Boris Katz

From owner-recombination@net.bio.net Fri Oct 27 22:00:00 1995
Path: biosci!CS.Arizona.EDU!uunet!in1.uu.net!newsfeed.internetmci.com!info.ucla.edu!library.ucla.edu!agate!news.ucdavis.edu!chip.ucdavis.edu!fznewt
From: Jeff 'Newt' Sekelsky <fznewt@peseta.ucdavis.edu>
Newsgroups: bionet.molbio.recombination
Subject: Re: RECOMBINATION/bionet.molbio.recombination is ready!
Date: Tue, 24 Oct 1995 10:48:17 -0700
Organization: University of California, Davis
Lines: 29
Message-ID: <Pine.SOL.3.91.951024082844.3666C-100000@rocky.ucdavis.edu>
NNTP-Posting-Host: chip.ucdavis.edu
Mime-Version: 1.0
Content-Type: TEXT/PLAIN; charset=US-ASCII
X-Sender: fznewt@chip.ucdavis.edu
In-Reply-To: <46eul1$r92@news.duke.edu> 

On 23 Oct 1995, Dan Tomso wrote:

> How do the frequencies of meiotic recombination events (e.g. gene 
> conversion) compare between S. cerevisiae and, say, Drosophila?
> 

Meiotic gene conversion is rare enough in Drosophila to make it difficult
to study.  Nonetheless, Art Chovnick and his colleagues have done
beautiful studies on conversion in the rosy (ry) gene.  Chovnick
determined the conversion frequencies of a number of alleles to be in the
range of 1/50,000 to 1/250,000.  The only reason the experiments can be
done is that one can select for ry+ recombinants by adding purine to the
medium.  Conversion frequencies are comparable at the few other loci in
which it's been measured (rudimentary, maroon-like, mei-41) which also 
have selections for wild-type recombinants. 

Exchange is probably also less frequent in Drosophila relative to yeast, 
measured either per chromosome, per genome, or per bp.  I don't know 
the numbers for S. cerevisiae, but for S. pombe, the chromosomes are 940, 
740, and 540 cM, corresponding to an average of 19, 15, and 11 exchanges 
per chromosome per meiosis.  In Drosophila, each of the five major 
chromosome arms is about 50-60 map units (I don't why Drosophila 
geneticists, of all people, don't use cM as the unit), corresponding to 
about one exchange per arm per meiosis.  Although there are regions where 
there seems to be more exchange per bp than expected, I'm unaware of any 
hot spots like those in yeast.

Jeff Sekelsky


From owner-recombination@net.bio.net Fri Oct 27 22:00:00 1995
Path: biosci!daresbury!hgmp.mrc.ac.uk!mraabe
From: mraabe@hgmp.mrc.ac.uk (Dr. M Raabe)
Newsgroups: bionet.molbio.recombination
Subject: Cre expressing mice
Date: 28 Oct 1995 14:42:09 GMT
Organization: UK HGMP Resource Centre
Lines: 14
Message-ID: <46tfg1$8om@mercury.hgmp.mrc.ac.uk>
NNTP-Posting-Host: tin.hgmp.mrc.ac.uk

Hi,

I am interested in mice expressing the Cre recombinase under tissue-specific 
promoters. Does anybody have mice with Cre expressing in hepatocytes or 
enterocytes or testis or yolk sac? Anybody interested in a collaboration on 
that? Is there any commercial dealer who has already set up such strains?
I would appreciate any informations.

Thank you, Martin

-----------------------------------------------------------------------
Martin Raabe                                 Phone: +49-251-836293
Institute for Atherosclerosis Research       FAX: +49-251-837225
University of Muenster, Germany              email: mraabe at hgmp.mrc.ac.uk

From owner-recombination@net.bio.net Fri Oct 27 22:00:00 1995
Path: biosci!agate!news.ucdavis.edu!library.ucla.edu!newsfeed.internetmci.com!in1.uu.net!utcsri!newsflash.concordia.ca!canopus.cc.umanitoba.ca!news
From: "R.D. Gietz" <gietz@cc.umanitoba.ca>
Newsgroups: bionet.molbio.recombination
Subject: CANADIAN PROFESSORS STRIKE FOR ACADEMIC FREEDOM
Date: 26 Oct 1995 22:11:02 GMT
Organization: University of Manitoba
Lines: 30
Message-ID: <46p11m$9m0@canopus.cc.umanitoba.ca>
NNTP-Posting-Host: gietz2.hgen.umanitoba.ca
Mime-Version: 1.0
Content-Type: text/plain; charset=us-ascii
Content-Transfer-Encoding: 7bit
X-Mailer: Mozilla 1.12(Macintosh; I; PPC)
X-URL: news:bionet.molbio.recombination

On October 17, 1995 Professors at the University of Manitoba, Winnipeg, 
Canada, went on strike in a bid to stop their administration (fully 
supported by a Conservative provincial government) from destroying 
academic freedom at our university. This strike is not about money. UMFA 
(University of Manitoba Faculty Association) has already offered to 
accept reduced wages sufficient to meet the difficult financial 
circumstances. The government is demanding the right to downsize by 
laying off staff in any department in an arbitrary manner. The proposed 
changes to our contract would allow the administration to fire 
individual 
professors who are challenging conventional wisdom, academics who speak 
out on public issues, and faculty who criticize the administration. 

WE ARE A TEST CASE AND IF WE FAIL, YOUR UNIVERSITY COULD BE NEXT. 
PLEASE, 
GIVE US YOUR SUPPORT. 

We wish to reach concerned academics world wide. If we have intruded 
onto 
your newsgroup with an off topic message, please excuse us.

For more information please consult http://www.xpressnet.com/umfa 
Letters of support to umfa@xpressnet.com
Letters of complaint to Premier Gary Filmon FAX: 204-949-1484 
(preferred) 
or premier@leg.gov.mb.ca





From owner-recombination@net.bio.net Sat Oct 28 22:00:00 1995
Path: biosci!agate!howland.reston.ans.net!newsfeed.internetmci.com!in2.uu.net!newsflash.concordia.ca!news.mcgill.ca!news
From: Graham Dellaire <popa0206@PO-Box.McGill.CA>
Newsgroups: bionet.molbio.recombination
Subject: Re: optimization for generating recombinant Adenoviruses
Date: 29 Oct 1995 17:39:54 GMT
Organization: McGill University Computing Centre
Lines: 23
Message-ID: <470e9a$5d1@sifon.cc.mcgill.ca>
References: <schreibr-251095195318@36.173.0.149>
NNTP-Posting-Host: q-07.das.mcgill.ca
X-Newsreader: AIR News 3.X (SPRY, Inc.)

>   schreibr@cmgm.stanford.edu (Edgar Schreiber) writes:
>  I would appreciate any comments and protocols that are  helpful to enhance
>  the frequency of plasmid to plasmid recombination in mammalian 293 cells
>  for the generation of recombinant Adenoviruses. Is electroporation more
>  "recombinogenic" than CaPO transfection ?
>  Thank you
>  Edgar
>  schreibr@cmgm.stanford.edu
>  
>>>>
Dear Edgar,

The main difference between Electroporation and CaPO4 precipitation is that with electroporation 
you get single molecules entering the nucleus rather than complexes of DNA molecules as in CaPO4.

The efficiencies are atleast two logs higher for CaPO4 precipation vs. electroporation.  Since this 
alone will increase the number of inter-plasmid recombination events this would be your best choice.

Graham Dellaire
Primary Discussion Leader
RECOM
dellaire@odyssee.net


From owner-recombination@net.bio.net Sat Oct 28 22:00:00 1995
Path: biosci!news.Stanford.EDU!agate!news.duke.edu!rpiv.mc.duke.edu!djt
From: djt@rpiv.mc.duke.edu (Dan Tomso)
Newsgroups: bionet.molbio.recombination
Subject: Thanks for help with Holliday junctions
Date: 24 Oct 1995 21:00:03 GMT
Organization: Duke University, Durham, NC, USA
Lines: 13
Message-ID: <46jk4j$d4c@news.duke.edu>
NNTP-Posting-Host: rpiv.mc.duke.edu
X-Newsreader: TIN [version 1.2 PL2]

Greetings.
	Thanks for all the responses.  For the curious, my original
question concerned mechanisms for resolving Holliday junctions that didn't
involve specific resolvase activities.  Most of the responses described
mechanisms that required branch migration up to a nick (or nicks), and
often involved conversion of the junction into replication forks.  
Topoisomerase resolution was also suggested.
	Is anybody aware of experiments which have specifically looked 
for these mechanisms?  For example, synthetic lethal screens or similar 
approaches in resolvase-deficient backgrounds?
				DT



From owner-recombination@net.bio.net Sun Oct 29 22:00:00 1995
Path: biosci!news.Stanford.EDU!agate!howland.reston.ans.net!newsfeed.internetmci.com!in2.uu.net!newsflash.concordia.ca!news.mcgill.ca!news
From: Graham Dellaire <popa0206@PO-Box.McGill.CA>
Newsgroups: bionet.molbio.recombination
Subject: WELCOME TO RECOM <repost>
Date: 29 Oct 1995 17:46:44 GMT
Organization: McGill University Computing Centre
Lines: 298
Message-ID: <470em4$5d1@sifon.cc.mcgill.ca>
NNTP-Posting-Host: q-07.das.mcgill.ca
X-Newsreader: AIR News 3.X (SPRY, Inc.)

***************************************************

BIONET.MOLBIO.RECOMBINATION is open FOR BUSINESS!!!

***************************************************

First of all I would like to thank everyone who has given input and 
support for the  creation of this news group.  Particularly those in
in the beginning who lent their support and ideas and eventually their 
vote!

Opening comments

1.If you wish to participate via NEWS primarily you should be forewarned
that the onus is upon you to ask your Institution to update their news feed and include
this new group.  This should be as easy as sending an e-mail to your local computing fascility or 
internet access provider (IAP) as the case maybe. (see below)

I myself have to do this and I am the principal discussion leader!

2. For those of you who do not have NEWS access (USENET  or BITNET etc), it possible to 
subscribe to the list service for this news group.  Please refer to the relevant sections below in the 
document provided by BIONET.

3. All suggestions for the content of our discussion are welcome.

so far suggestions that may be adopted are as follows:

	a)Job Listing (post doc, Institution listings etc)

	b)Postings of concise editorials on given areas of participants expertise
	
	c)Postings of abstracts from recently published works or from pre-prints where 	
	  applicable 

                                                                     
	d)Postings of dates and sites of upcoming meetings
	
	e)Posting of brief resumes of the events of the recent meetings.

	f)Posting of a recombination FAQ including:
		-reference lists for separate topics in recombination
		-lists of web resources (FTP,GOPHER etc) for genetics and recombination
		-broad introductory sections on particular aspects of recombination to 	
		be contributed by participants in the group.
		-news group charter
		-contact information for discussion leaders
			-perhaps posting of addresses of institutions that work in 	
		genetics as well as key laboratories (basically if you give me 		
		your address we will try to include it)                                                               


Well that is all for now, thank you again for your support and  
hope to see you in  future discussions in bionet.molbio.recombination

Below is a blurb on how to subscribe and how to notify your news provider 
so they update their list of groups to include our recombination new group.

Graham
dellaire@odyssee.net

****note: please use this address for all correspondance (dellaire@odyssee.net).****



<---- Begin Included Message ---->

Subject: RECOMBINATION is ready!
Cc: biosci-help@net.bio.net


This just went out on your newsgroup as well as bionet.announce and
bionet.general.

Best wishes!

				Sincerely,

				Dave Kristofferson
				BIOSCI/bionet Manager

				biosci-help@net.bio.net


Newsgroups: bionet.molbio.recombination
Subject: RECOMBINATION/bionet.molbio.recombination is ready!
Distribution: world
Organization: BIOSCI International Newsgroups for Biology

The RECOMBINATION/bionet.molbio.recombination newsgroup is ready for
operation.  Please save these usage instructions for future
reference!!

PLEASE NOTE that many USENET sites do not allow automatic creation of
new USENET groups!!!  If you do not see bionet.molbio.recombination in your
newsreader within another day or two, ask your news system
administrator to act on our "newgroup" message to enable the group at
your site.  We have already done several tests and are certain that
the group is currently propagating around the network.  If he/she can
not find the newsgroup message, have them retrieve the bionet
checkgroups message from the anonymous FTP area on net.bio.net in
pub/BIOSCI/doc/bionet-checkgroups-msg.  This file contains the latest
list of bionet USENET newsgroups and can be used to update your bionet
distribution.  If the newgroup did not arrive at your site, it may
also be necessary for your news administrator to contact the upstream
computer site providing you with your newsfeed and determine if they
acted on the newgroup message.

Subscribing to this group:
--------------------------

IF YOU USE USENET NEWS: you need do nothing other than participate in
bionet.molbio.recombination when it appears in your newsreader.  Depending
upon your news software, this may entail you having to answer a prompt
indicating that you want to subscribe.  You might also try the command
"g bionet.molbio.recombination" in rn-like newsreaders.

IF YOU ARE LOCATED IN EUROPE, AFRICA, OR CENTRAL ASIA: please send the
word

help

in the body of your message to MXT@dl.ac.uk to retrieve general server
usage instructions.  To subscribe to the RECOMBINATION list, first
be sure that you are sending mail from the address at which you wish
to receive news postings, and then send
the command

SUB bionet-news.bionet.molbio.recombination

to MXT@dl.ac.uk.  This message will be automatically read by the
computer and your e-mail address will be extracted from the mail
header and added to the list.


IF YOU ARE LOCATED IN THE AMERICAS OR THE PACIFIC RIM: log in to the
computer account in which you would like to receive mail (not an
account that you use infrequently) and send a mail message to the
Internet address

biosci-server@net.bio.net

Leave the Subject: line of the message blank and enter the following
line into the body of the mail message:

subscribe recom


This message will be automatically read by our computer and your
e-mail address will be extracted from the mail header and added to the
list.


Canceling your subscription:
----------------------------

IF YOU ARE LOCATED IN EUROPE, AFRICA, OR CENTRAL ASIA: first be sure
that you are sending mail from the address at which you signed up to
receive news postings, and then send the command (in the body of your
mail message)

UNSUB bionet-news.bionet.molbio.recombination

to MXT@dl.ac.uk.  This message will be automatically read by the
computer and your e-mail address will be extracted from the mail
header and removed from the list.

IF YOU ARE LOCATED IN THE AMERICAS OR THE PACIFIC RIM: send a message
to biosci-server@net.bio.net exactly as described above for
subscribing except include the text

unsubscribe recom

in the body of the message.  Please be sure to send the message from
the account whose address matches the one on the list.  If your
address differs, we will be notified automatically and will remove you
manually from the list if we can determine what was your old address.
Please contact biosci-help@net.bio.net if you have problems.


IF YOU HAVE A PROBLEM:
----------------------

Please send a message to one of the following addresses depending upon
your location

Address                              Location
-------                              --------
biosci@daresbury.ac.uk               Europe, Africa, and Central Asia
biosci-help@net.bio.net              Americas and the Pacific Rim

and someone on the staff will help you.  PLEASE DO NOT send mail to
our personal e-mail addresses as this will delay a response to your
request for help.


How to post a message to the group:
-----------------------------------

If you use news, simply post a message into bionet.molbio.recombination.  Be
sure to set your "distribution" to "world" or else the message might
not leave your site!!

To post by e-mail, mail your message to one of the following addresses
depending upon your location:

Posting Address                      Location
---------------                      --------
recom@daresbury.ac.uk                Europe, Africa, and Central Asia
recom@net.bio.net                    Americas and the Pacific Rim

and your message will be distributed automatically to everyone on the
list and the USENET newsgroup.  There is no editorial intervention.

PLEASE DO NOT SEND SUBSCRIPTION REQUESTS TO THE POSTING ADDRESSES as
you will bother everyone on the newsgroup!!!


How to reply to a message on the group:
---------------------------------------

If you are using a newsreader, simply use the reply or follow-up
command on your newsreader (these vary from program to program) to
send either private or public replies.

If you are using e-mail, replies to messages that you receive will
*NOT* be automatically returned to the group.  This is the standard
for Internet mailing lists as opposed to BITNET LISTSERVs which often
send all replies back to everyone.  You must be certain that your
reply contains either of the two newsgroup posting addresses above in
your message header if you want to share it with everyone on the
group.  Otherwise in most cases your reply may go back to only the
original poster of the message to which you are replying.

ALWAYS be certain that you examine the address on your messages before
you send them!!!  Once a message is sent there is no way to cancel it
or bring it back!!!  Some non-Internet compliant mail systems may
attempt to send replies to our error-trapping address called
BIOSCI-REQUEST.  If yours does this, please be sure to readdress your
message to recom@net.bio.net or recom@daresbury.ac.uk if you want
to send it to the newsgroup.


How to look at archives of the list:
------------------------------------

The BIOSCI archives and other BIOSCI information can be found on our
WWW home page at URL http://www.bio.net/.  Easy access from the WWW
home page to our FTP/gopher area is available for information
retrieval.

Archives for RECOMBINATION/bionet.molbio.recombination are kept in the
anonymous FTP account at net.bio.net [204.31.212.2].  Look in the
directory pub/BIOSCI/RECOMBINATION for posting archives.  Each file
is assigned a date such as 9312 for December 1993.  Please note that
ours is a UNIX system and all file and directory names are
case-sensitive, i.e., upper case file names are different from lower
case names. 

You can also access these same files via Gopher if you start a gopher
session using net.bio.net as your gopher server.  Gopher also allows
you to view the individual messages within each monthly archive file.
The files are in the RECOMBINATION directory.  Postings to
bionet.molbio.recombination are also WAIS indexed and can be searched
via either gopher or WAIS at our site.  In gopher the option at
net.bio.net is "Search Bionet USENET Articles" and in WAIS one should
use the WAIS source biosci.src.  This is a WAIS index of all
BIOSCI/bionet messages including this newsgroup.  Please see the
BIOSCI FAQ for details.  The FAQ can be requested from
biosci-help@net.bio.net.

Once again, if you have any administrative questions that require
personal assistance, please address them to biosci-help@net.bio.net in
the U.S. or biosci@daresbury.ac.uk in the UK.

Best wishes for a successful newsgroup!

				Sincerely,

				Dave Kristofferson
				BIOSCI/bionet Manager

				biosci-help@net.bio.net


<---- End Included Message ---->


Primary Discussion leader
RECOM

Graham Dellaire
Faculty of Medicine
McGill University
Div. of Experimental Medicine

e-mail:dellaire@odyssee.net


From owner-recombination@net.bio.net Mon Oct 30 22:00:00 1995
Path: biosci!ATLAS.ODYSSEE.NET!dellaire
From: dellaire@ATLAS.ODYSSEE.NET (Dellaire, Graham)
Newsgroups: bionet.molbio.recombination
Subject: CAVEAT on POSTS TO RECOM (or any other group for that matter)
Date: 31 Oct 1995 15:35:08 -0800
Organization: BIOSCI International Newsgroups for Molecular Biology
Lines: 61
Sender: daemon@net.bio.net
Distribution: world
Message-ID: <9510312332.AA15921@odyssee.net>
NNTP-Posting-Host: net.bio.net

***************RECOM DISCLAIMER ****************

=================================================

Although bionet does archive material posted to its groups this does not
ensure protection to intellectual property (ideas, protocols, etc.)

Essentially anything posted to RECOM may be considered *PUBLIC DOMAIN*.

It may become prudent in the future to acknowledge contributions by
particular participants in any group but it is on the initiative and
judgment  of each individual at this point.

I would like to mention that in the beginning before there was a RECOM news
group I was approached by _ Derwent Information limited_, a company involved
in biomedical patents and the publisher of the GENE THERAPY news letter.
They showed interest in abstracting posts from this group.  If this should
occur and set a precedent for publishing of  bionet posts in news letters
and journals, once published such posts would become bonafide intellectual
property which can be protected by law.  


I encourage such publishing at face value... BUT definite guidelines should
be drawn up and I hope that we in this group can develop at least some
preliminary guidelines for those parties that wish to republish our
contributions to this news group.



Here are a few guideline I suggest we adopt

1.  At all times parties involved must be notified in advance that there
post is to be published.

2. Any changes to there post must be approved by the party responsible for
its posting.

3. Full name, date and news group must be included when a post is referenced
or republished in any form
 


Further additions/discussion to these guidelines is encouraged

Graham Dellaire
Primary Discussion leader
RECOM

dellaire@odyssee.net 


********************************************************
Graham Dellaire                            Snail Mail
Div. of Experimental Medicine           Institute du Cancer de Montreal
Dept. of Medicine                               Louis Charles-Simard 
McGill University                              1560 Sherbrooke Street E.
e-mail:dellaire@odyssee.net                Montreal, Quebec, Canada
or B2XE@musicb.mcgill.ca    
********************************************************



From owner-recombination@net.bio.net Mon Oct 30 22:00:00 1995
Newsgroups: bionet.molbio.recombination
Path: biosci!agate!howland.reston.ans.net!newsfeed.internetmci.com!in1.uu.net!nih-csl!NewsWatcher!user
From: lichten@helix.nih.gov (Michael Lichten)
Subject: Re: RECOMBINATION/bionet.molbio.recombination is ready!
Message-ID: <lichten-3110950921400001@128.231.218.92>
Sender: postman@alw.nih.gov (AMDS Postmaster)
Nntp-Posting-Host: 128.231.218.92
Organization: LB/DCBDC/NCI
References: <45v661$lqr@net.bio.net> <468aog$se0@epervier.CC.UMontreal.CA> <46eul1$r92@news.duke.edu>
Date: Tue, 31 Oct 1995 13:21:40 GMT
Lines: 20

I'd like to amplify Dan Tomso's comments, re yeast being more
"recombinogenic" than us (be we mice or men).  As Dan implies, the
problems in making this comparison is that different assays are being used
in the two organisms, and one can't tell if the different results are an
artefact of the assay or reflect basic differences in mechanism.  I would
be curious to hear what others felt would be a good trans-species assay
for recombination that might allow such a comparison.  

I have one suggestion:  the efficiency and means of repair of a defined,
induced double-strand break.  Systems exist in both yeast and in mice to
make a single DSB in the genome by inducing expression of a rare-cutting
homing endonuclease.  How yeast deals with this has been the subject of
intensive study; results are just beginning to come in from transgenic
mouse experiments.

Anyone have any other ideas?

-- 
Michael Lichten
lichten@helix.nih.gov

From owner-recombination@net.bio.net Mon Oct 30 22:00:00 1995
Path: biosci!ATLAS.ODYSSEE.NET!dellaire
From: dellaire@ATLAS.ODYSSEE.NET (Dellaire, Graham)
Newsgroups: bionet.molbio.recombination
Subject: Abstract: Unequal homologous recombination of Human DNA on YAC
Date: 31 Oct 1995 15:15:30 -0800
Organization: BIOSCI International Newsgroups for Molecular Biology
Lines: 92
Sender: daemon@net.bio.net
Distribution: world
Message-ID: <9510312311.AA14634@odyssee.net>
NNTP-Posting-Host: net.bio.net

The following is an interesting abstract I found recently that looks at
cross species recombination in a different manner. And for the on going
thread with Dr. Lichten and Dan Tomaso I have included a rough rational for
an experiment.

UNEQUAL HOMOLOGOUS RECOMBINATION OF HUMAN DNA ON A YEAST ARTIFICIAL CHROMOSOME
Campbell et al (1995)

NAR vol 23, no 18 pp 3691-3695

ABSTRACT

We examined unequal homolgous DNA recombination between  human repetitive
DNA elements located on a yeast artificial chromosome (YAC) and transforming
plasmid molecules.  A plasmid vector containing an ALU element, as well as a
sequence identical to a unique site on a YAC, was introduced into yeast and
double recombinant clones anallyzed.  Recombination occurs between vector
and YAC Alu elements sharing as little as 74% identity,  The physical
proximity of an Alu element to the unique DNA segment appears to play a
significant role in determining the frequency with which that element serves
as a recombination substrate.  In addition, cross-over points of the
recombination reaction are largely confined to the ends of the repetitive
element.  Since a similar distribution of crossover sites occurs during
unequal homologous recombination in human germ and somatic tissue, we
propose that similar enzymatic processes may be responsible for the events
observed in our system and in human cells.  This suggest that a further
examination of the enzymology of unequal  homologous recombination of human
DNA within yeast may yield a greater understanding of the molecular events
which control this process in higher eukaryotes.


comment:

From these experiments it seems yeast and eukaryotic recombination involving
unequal cross over may be quite similar. Using this  system as a base you
could first clone a well studied region of human genome in YAC and carry out
the same recombination targeting with the plasmid in yeast and in human cells.  

TO answer the DBS break repair questions in this thread 
 (see RE: Re: RECOMBINATION/bionet.molbio.recombination is ready)
which was how does DSB repair and recombination differ between Yeast and
man, you could do the following.  As eluded to by Dr. Lichten .... rare
cutting enzymes are useful to make a single DSB in a target molecule.

Place in your human cell line(by gene transfer) a gene construct containing
a very rare single cutter not normally present in yeast or human cells.  You
clone the genomic region containing this target locus into a YAC.  

You then have to express your rare cutter in your yeast and human cells at
the same time as you transform your "ectopic" vector.  To do this just
transform your yeast and human cells with two vectors one with a gene
encoding your rare cutting restriction enzyme and one with your
recombination substrate.

Reconstruction of drug resistance genes (ex neo) or gene marker (ex green
fluorescent protein) can be used for scoring recombination and  to determine
a frequency of recombination. 


Graham Dellaire 
Experimental Medicine
McGill University

P.S. If anyone tries this I would like a reprint someday (hehe)  Funny
enough bionet does 
archive all this material so as soon as I send this there is a copy
somewhere.  Although it can be said that anything on the net is PUBLIC
DOMAIN, it may become prudent in the future to acknowledge contributions no
matter where they appear.

 In particular I would like to mention that in the beginning before there
was a RECOM news group Derwent Information limited... involved in patents
and publisher of the GENE THERAPY news letter showed interest in abstracting
posts from this group.  This would further the idea of a precedent for
intellectual property on the internet and at face value I welcome it. 

 BUT definite guidelines should be drawn up and I hope that we in this group
could discuss these.




********************************************************
Graham Dellaire                            Snail Mail
Div. of Experimental Medicine           Institute du Cancer de Montreal
Dept. of Medicine                               Louis Charles-Simard 
McGill University                              1560 Sherbrooke Street E.
e-mail:dellaire@odyssee.net                Montreal, Quebec, Canada
or B2XE@musicb.mcgill.ca    
********************************************************



From owner-recombination@net.bio.net Mon Oct 30 22:00:00 1995
Path: biosci!ATLAS.ODYSSEE.NET!dellaire
From: dellaire@ATLAS.ODYSSEE.NET (Dellaire, Graham)
Newsgroups: bionet.molbio.recombination
Subject: Repost of Comments on NAR ( Campbell et al. 1995)
Date: 31 Oct 1995 15:41:09 -0800
Organization: BIOSCI International Newsgroups for Molecular Biology
Lines: 71
Sender: daemon@net.bio.net
Distribution: world
Message-ID: <9510312338.AA16320@odyssee.net>
NNTP-Posting-Host: net.bio.net

My E-mail client clipped my comments from the abstract and posted them under 

","   so I will repost them


In regards to the NAR (Campbell et al 1995)abstract post here are my
original comments

----------------------------------------------------------------------------

comment:

From these experiments it seems yeast and eukaryotic recombination involving
unequal cross over may be quite similar. Using this  system as a base you
could first clone a well studied region of human genome in YAC and carry out
the same recombination targeting with the plasmid in yeast and in human cells.  

TO answer the DBS break repair questions in this thread 
 (see RE: Re: RECOMBINATION/bionet.molbio.recombination is ready)
which was how does DSB repair and recombination differ between Yeast and
man, you could do the following.  As eluded to by Dr. Lichten .... rare
cutting enzymes are useful to make a single DSB in a target molecule.

Place in your human cell line(by gene transfer) a gene construct containing
a very rare single cutter not normally present in yeast or human cells.  You
clone the genomic region containing this target locus into a YAC.  

You then have to express your rare cutter in your yeast and human cells at
the same time as you transform your "ectopic" vector.  To do this just
transform your yeast and human cells with two vectors one with a gene
encoding your rare cutting restriction enzyme and one with your
recombination substrate.

Reconstruction of drug resistance genes (ex neo) or gene marker (ex green
fluorescent protein) can be used for scoring recombination and  to determine
a frequency of recombination. 


Graham Dellaire 
Experimental Medicine
McGill University

P.S. If anyone tries this I would like a reprint someday (hehe)  Funny
enough bionet does 
archive all this material so as soon as I send this there is a copy
somewhere.  Although it can be said that anything on the net is PUBLIC
DOMAIN, it may become prudent in the future to acknowledge contributions no
matter where they appear.

 In particular I would like to mention that in the beginning before there
was a RECOM news group Derwent Information limited... involved in patents
and publisher of the GENE THERAPY news letter showed interest in abstracting
posts from this group.  This would further the idea of a precedent for
intellectual property on the internet and at face value I welcome it. 

 BUT definite guidelines should be drawn up and I hope that we in this group
could discuss these.

Graham


********************************************************
Graham Dellaire                            Snail Mail
Div. of Experimental Medicine           Institute du Cancer de Montreal
Dept. of Medicine                               Louis Charles-Simard 
McGill University                              1560 Sherbrooke Street E.
e-mail:dellaire@odyssee.net                Montreal, Quebec, Canada
or B2XE@musicb.mcgill.ca    
********************************************************



